GIM
PBH icon

Glenmede Investment Management’s Prestige Consumer Healthcare PBH Stock Holding History

Glenmede Investment Management’s Portfolio PBH Stock Details PBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$15.7M Sell
251,369
-15,058
-6% -$1.05M 0.08% 237
2025
Q2 		$21.3M Buy
+266,427
New +$22.3M 0.11% 167

Other funds holding PBH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
WHG
Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return

Glenmede Investment Management's PBH Position: Q3 2025 in Review

Glenmede Investment Management reduced its Prestige Consumer Healthcare (PBH) stake by 5.7% in Q3 2025, selling an estimated $1.05M and leaving 251,369 shares worth $15.7M. The position accounts for 0.08% of the portfolio, ranked #237.

Glenmede Investment Management first reported a position in PBH in Q2 2025 and has held it in 2 quarters since. The position peaked at $21.3M in Q2 2025. 356 funds tracked by Wall St. Rank hold PBH as of Q3 2025.

  • Glenmede Investment Management held 251,369 shares of Prestige Consumer Healthcare worth $15.7M as of Q3 2025.
  • Glenmede Investment Management sold 15,058 Prestige Consumer Healthcare shares in Q3 2025, an estimated $1.05M.
  • Prestige Consumer Healthcare made up 0.08% of Glenmede Investment Management's portfolio in Q3 2025, its #237 holding.
  • Glenmede Investment Management first reported a position in Prestige Consumer Healthcare in Q2 2025 and has held it in 2 quarters since.
  • Glenmede Investment Management's Prestige Consumer Healthcare position peaked at $21.3M in Q2 2025.
  • 356 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q3 2025.

Based on Glenmede Investment Management's 13F filing for Q3 2025, filed 13 Nov 2025.